Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 7:52 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 937–960 of 971 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Control (standard practice) Clear all

Conditions: Depression, Anxiety, Substance Use Disorder (SUD), Post Traumatic Stress Disorder
Interventions: Microcurrent Neurofeedback (MCN), Standard Care for Substance Use Disorder; Device · Behavioral
Lead sponsor: University of Alabama, Tuscaloosa; Other
Eligibility: 18 Years to 65 Years
Enrollment: 61 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Tuscaloosa, Alabama

Conditions: Pre Diabetes
Interventions: Exenatide SR; Drug
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 9 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Clinical Stage II Esophageal Adenocarcinoma AJCC v8, Clinical Stage II Esophageal Squamous Cell Carcinoma AJCC v8, Clinical Stage II Gastric Cancer AJCC v8, Clinical Stage III Esophageal Adenocarcinoma AJCC v8, Clinical Stage III Esophageal Squamous Cell Carcinoma AJCC v8, Clinical Stage III Gastric Cancer AJCC v8, Clinical Stage IV Esophageal Adenocarcinoma AJCC v8, Clinical Stage IV Esophageal Squamous Cell Carcinoma AJCC v8, Clinical Stage IV Gastric Cancer AJCC v8, Stage II Pancreatic Cancer AJCC v8, Stage III Pancreatic Cancer AJCC v8, Stage IV Pancreatic Cancer AJCC v8
Interventions: Acupressure Therapy, Best Practice, Biospecimen Collection, Questionnaire Administration; Procedure · Other
Lead sponsor: University of Washington; Other
Eligibility: 18 Years to 65 Years
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Sickle Cell Disease
Interventions: WE CARE SDoH Screening Survey, Family Resource Book, Standard of care; Behavioral · Other
Lead sponsor: Boston Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 112 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Accidental Falls, Wounds and Injuries
Interventions: Evidence-based tailored fall prevention, Usual care; Other
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 70 Years and older
Enrollment: 5,451 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2020
U.S. locations: 10
States / cities: Torrance, California • Des Moines, Iowa • Baltimore, Maryland + 7 more

Conditions: Vital Sign Evaluation, Vital Sign Monitoring, Sleep Quality, Provider Behavior, Patient Satisfaction
Interventions: Device Array Use, Routine Vital Sign Measurement; Device
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years and older
Enrollment: 270 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 2
States / cities: Chicago, Illinois

Conditions: Asthma, Chronic School Absenteeism
Interventions: Home Visit, Standard Care; Behavioral
Lead sponsor: University of California, Davis; Other
Eligibility: 5 Years to 12 Years
Enrollment: 11 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Sacramento, California

Conditions: End Stage Renal Disease
Interventions: Patient-Guided, Educator-Guided; Other
Lead sponsor: The Methodist Hospital Research Institute; Other
Eligibility: 18 Years to 74 Years
Enrollment: 558 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Hypotension During Cesarean Delivery, Spinal Anesthesia
Interventions: Cardiac output monitor data; Device
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years to 40 Years · Female only
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Long COVID, Post-Acute COVID-19 Syndrome
Interventions: Amantadine, Physical, Occupational, Speech Therapy, Provider Counseling, Medications for symptoms management; Drug · Other
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 20 Years to 65 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Anorexia Nervosa
Interventions: CRT + Teach the Parent, CRT + Contact Control; Behavioral
Lead sponsor: Children's Hospital of Philadelphia; Other
Eligibility: 12 Years to 18 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Fracture Forearm, Pediatric ALL
Interventions: Tablet-based educational intervention; Behavioral
Lead sponsor: Louisiana State University Health Sciences Center in New Orleans; Other
Eligibility: 0 Years to 18 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: New Orleans, Louisiana

Conditions: Lung Cancer
Interventions: Mindful Self-Compassion for Lung Cancer (MSC-LC), Enhanced standard of care with waitlist; Behavioral · Other
Lead sponsor: Loyola Marymount University; Other
Eligibility: 18 Years to 100 Years
Enrollment: 79 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Pulmonary Disease, Chronic Obstructive
Interventions: Placebo ELLIPTA, Nemiralisib ELLIPTA 50 µg, Nemiralisib ELLIPTA 100 µg, Nemiralisib ELLIPTA 250 µg, Nemiralisib ELLIPTA 500 µg, Nemiralisib ELLIPTA 750 µg, Albuterol (Salbutamol) MDI or nebules, Standard of care therapy; Drug
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 40 Years to 80 Years
Enrollment: 943 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 21
States / cities: Mobile, Alabama • Colorado Springs, Colorado • Daytona Beach, Florida + 17 more

Conditions: Motor Activity
Interventions: CSPAP; Behavioral
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 5 Years to 12 Years
Enrollment: 599 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: Columbia, South Carolina

Conditions: Chronic Pain, Pain, Musculoskeletal, Opioid Use, Physical Therapy
Interventions: Mindfulness based practice, Control/Standard Physical Therapy; Behavioral
Lead sponsor: University of Utah; Other
Eligibility: 18 Years to 75 Years
Enrollment: 93 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2025
U.S. locations: 2
States / cities: Gainesville, Florida • Salt Lake City, Utah

Conditions: Post Operative Surgical Site Infection
Interventions: Vancomycin antibiotic powder; Drug
Lead sponsor: Major Extremity Trauma Research Consortium; Other
Eligibility: 18 Years to 80 Years
Enrollment: 1,036 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2019
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Post Partum Hemorrhage
Interventions: Novel PPH Risk Prediction Model - Comparator Arm B; Behavioral
Lead sponsor: Holly Ende; Other
Eligibility: Female only
Enrollment: 12,500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Opioid Misuse, Trauma Injury
Interventions: Opioid Risk Monitoring (ORM), enhanced Trauma Care Coordination (eTCC), Pain Coping Skills Training - Brief (PCST-LITE), Standard Trauma Care Coordination (sTCC), Pain Coping Skills Training - Plus (PCST+), Pain Coping Skills Training - Maintenance (PCST-M); Other · Behavioral
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 18 Years to 65 Years
Enrollment: 118 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 2
States / cities: Madison, Wisconsin • Milwaukee, Wisconsin

Conditions: Breast Cancer
Interventions: Polysomnography (PSG), Rectal thermistor 400 Series, Bright blue-green light, Dim red light, Digital foot candle datalogging light meter, Patient-Reported Outcomes Measurement Information System (PROMIS)-Cancer-Fatigue, Patient-Reported Outcomes Measurement Information System (PROMIS)-Sleep Disturbance, Patient-Reported Outcomes Measurement Information System (PROMIS)-Depression, Patient-Reported Outcomes Measurement Information System (PROMIS)-Physical Function, Pittsburgh Sleep Quality Index (PSQI), Center for Epidemiological Studies - Depression, Montreal Cognitive Assessment (MoCA), European Organization for Research and Treatment of Cancer-Quality of Life Questionnaire (EORTC QLQ-C30), Daily Log; Diagnostic Test · Other
Lead sponsor: Michigan State University; Other
Eligibility: 21 Years and older · Female only
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2022
U.S. locations: 1
States / cities: East Lansing, Michigan

Conditions: Chemotherapy Side Effects, Taste, Altered
Interventions: Taste Alteration Self-Assessment, Taste Alternation Self-Management; Behavioral
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years and older
Enrollment: 400 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Substance Use Disorders
Interventions: Recovery Coach Intervention; Behavioral
Lead sponsor: Prisma Health-Upstate; Other
Eligibility: 18 Years to 60 Years
Enrollment: 99 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Greenville, South Carolina

Conditions: Hypertension, Heart Failure
Interventions: Clevidipine, Standard of Care IV antihypertensive; Drug
Lead sponsor: The Medicines Company; Industry
Eligibility: 18 Years and older
Enrollment: 117 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2012
U.S. locations: 9
States / cities: Montgomery, Alabama • Inglewood, California • Baton Rouge, Louisiana + 6 more

Conditions: Sickle Cell Disease
Interventions: I-STRONG, Enhanced Usual Care (EUC); Behavioral · Other
Lead sponsor: Emory University; Other
Eligibility: 12 Years to 18 Years
Enrollment: 155 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 4
States / cities: Hartford, Connecticut • Atlanta, Georgia • Cincinnati, Ohio

Search by objective public record fields.

Microcurrent Neurofeedback as an Adjunct to Standard Care for Substance Use Disorders

Assess the Efficacy and Safety of Exenatide SR for the Prevention of Diabetes After Kidney Transplantation

Feasibility of Auricular Acupressure for Appetite and Weight in Patients With Stage II-IV Gastric, Esophageal, and Pancreatic Cancer

Sickle Cell Anemia WE CARE

Strategies to Reduce Injuries and Develop Confidence in Elders

Effect of ANNE One-Wellue Device Array Use on Staff Bedside Vital Sign Measurement Activity

Home Visits to Optimize Medical and Educational Success Among Sacramento Schoolchildren With Asthma

Explore Transplant at Home: Improving Low-Income ESRD Patients' Transplant Knowledge

Ninvasive Cardiac Output Measurements During Cesarean Delivery Under Spinal Anesthesia.

A Study of Amantadine for Cognitive Dysfunction in Patients With Long-Covid

Cognitive Remediation Therapy for Adolescents With Anorexia Nervosa

Taking POSNA's OrthoKids to the People

Adapting and Testing a Novel Self-Compassion Intervention to Reduce Lung Cancer Stigma

Dose Finding Study of Nemiralisib (GSK2269557) in Subjects With an Acute Moderate or Severe Exacerbation of Chronic Obstructive Pulmonary Disease (COPD)

Be a Champion! Comprehensive School Physical Activity Program

Physical Therapy Integrated With Mindfulness for Patients With Chronic Pain and Opioid Treatment

Local Antibiotic Therapy to Reduce Infection After Operative Treatment of Fractures at High Risk of Infection: A Multicenter Randomized, Controlled Trial (VANCO)

A Pragmatic Randomized Controlled Trial to Predict Postpartum Hemorrhage

Screening in Trauma for Opioid Misuse Prevention - an Adaptive Intervention

Effects of Bright Light on Co-occurring Cancer-related Symptoms in Breast Cancer Survivors

Taste Alterations Study

Barriers to Substance Use Disorder Recovery

Clevidipine in the Treatment of Blood Pressure in Patients With Acute Heart Failure (PRONTO)

Integrative Training Program for Pediatric Sickle Cell Pain